Fabio Cataldi - AbbVie | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 107 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Effect of NLRX1 Activation on Eosinophils in Ulcerative Colitis and Inflammation: Translational Learnings Across Diseases and from Mouse to Human

B. Verstockt,M. Dubinsky,L. Peyrin-Biroulet,R. Mosig,F. Cataldi,S. Vermeire

JOURNAL OF CROHNS & COLITISno. 5 (2024): I1109-I1110

引用0浏览0引用

Translating Pharmacokinetic and Efficacy Outcomes of NLRX1 Agonist NX-13: Contrasting a Pig Model and a Human Phase 1b Clinical Trial in Ulcerative Colitis

B. Siegmund,B. Verstockt,M. Dubinsky,R. Mosig,F. Cataldi,S. Danese,A. Yarur

JOURNAL OF CROHNS & COLITISno. Supplement_1 (2024): I1374-I1374

引用0浏览0引用

Efficacy and Safety of the Anti-mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn's Disease

Severine Vermeire,Silvio Danese,William J. Sandborn,Stefan Schreiber,Stephen Hanauer,Geert D'Haens,Peter Nagy,Manoj Thakur,Caleb Bliss,Fabio Cataldi,Martina Goetsch,Kenneth J. Gorelick,Walter Reinisch

JOURNAL OF CROHNS & COLITISno. 5 (2024): 708-719

引用0浏览0WOS引用

P571 the Effect of NLRX1 Activation on Eosinophils in Ulcerative Colitis and Inflammation: Translational Learnings Across Diseases and from Mouse to Human

Bram Verstockt,Marla C. Dubinsky,Laurent Peyrin–Biroulet,Rebecca Mosig,Fabio Cataldi,Séverine Vermeire

Journal of Crohn's and colitisno. Supplement_1 (2024): i1116-i1117

引用0浏览0引用

Tu1737 ROLE OF NLRX1 AGONIST NX-13 IN REDUCING VISCERAL HYPERSENSITIVITY IN PRECLINICAL GASTROINTESTINAL INFLAMMATION

B. Verstockt,S. Vermeire,L. Peyrin-Biroulet,A. Yarur,R. Panaccione,R. Mosig,F. Cataldi,S. Danese

Gastroenterologyno. 5 (2024): S-1400

引用0浏览0引用

The Immunometabolic Bimodal Mechanism of NLRX1 Agonist NX-13 in a Pig Model of Ulcerative Colitis

B. Verstockt,R. Mosig,M. Dubinsky,F. Cataldi,S. Danese

JOURNAL OF CROHNS & COLITIS (2024): I344-I345

引用0浏览0引用

P144 Modulation of Immunometabolism Via NLRX1 or PLXDC2: Novel Bimodal Mechanisms for the Treatment of Inflammatory Bowel Diseases

Silvio Danese,J F Colombel,Florian Rieder,Laurent Peyrin‐Biroulet,B Siegmund,Séverine Vermeire, M Dubinsky,Stefan Schreiber,Andrés Yarur,Remo Panaccione,Brian G. Feagan,Rebecca Mosig,Fabio Cataldi,Bram Verstockt

Journal of Crohn's and colitisno. Supplement_1 (2024): i443-i445

引用0浏览0引用

Modulation of Immunometabolism via NLRX1 or PLXDC2: Novel Bimodal Mechanisms for the Treatment of Inflammatory Bowel Diseases

S. Danese,J. F. Colombel,F. Rieder,L. Peyrin-Biroulet,B. Siegmund,S. Vermeire,M. Dubinsky, S. Schreiber,A. Yarur,R. Panaccione,B. Feagan,R. Mosig,F. Cataldi,B. Verstockt

JOURNAL OF CROHNS & COLITIS (2024): I439-I440

引用0浏览0引用

P114 Role of NLRX1 Agonist NX-13 in Reducing Visceral Hypersensitivity in Preclinical Gastrointestinal Inflammation

Bram Verstockt,Séverine Vermeire,Laurent Peyrin‐Biroulet,Andrés Yarur,Remo Panaccione,Rebecca Mosig,Fabio Cataldi,Silvio Danese

Journal of Crohn's and colitisno. Supplement_1 (2024): i400-i401

引用0浏览0引用

635 EFFICACY AND SAFETY OF THE SELECTIVE SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR, ETRASIMOD, IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS OVER 52 WEEKS IN THE PHASE 2 VOYAGE STUDY

Evan S. Dellon,Margaret H. Collins,Arjan Bredenoord,Hamish Philpott,Luc Biedermann, Márjori Dulcine,Thai Nguyen-Cleary,Chinyu Su, Jin Yu,Huaming Tan,Fabio Cataldi,Hanzhe Zheng,Wenjin Wang, Pamela Clax,John Woolcott,Ikuo Hirano

Gastroenterologyno. 5 (2024): S-146-S-147

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn